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Imaging Highlights From the 2008 Scientiﬁc
Session of the American College of Cardiology
Joanne D. Schuijf, PHD,* Jacob M. van Werkhoven, MD,* Anna Woo, MD, FACC,†
Harry Rakowski, MD, FACC†
Leiden, the Netherlands; and Toronto, Ontario, CanadaThe 57th Annual Scientific Session of the Ameri-
can College of Cardiology brought together about
30,000 physicians, scientists, and health care pro-
fessionals from around the world to share informa-
tion and opinions about the latest developments in
cardiovascular medicine. The imaging sessions from
this year’s meeting in Chicago included presenta-
tions dealing both with novel technology and the
prognostic value of imaging studies used in everyday
clinical practice. There is an increasing need to link
imaging studies with disease management, progno-
sis, and cost-effectiveness. The highlighted imaging
presentations address these issues.
Survival After High Risk Myocardial Infarction:
Not Just Ejection Fraction
Echocardiography remains the most widely used
noninvasive imaging test in patients who suffer a
myocardial infarction (MI). Although the initial
goal is often the evaluation of left ventricular (LV)
dysfunction and the exclusion of mechanical com-
plications, there is an increasing focus on the
prognostic implications of diastolic dysfunction and
on new measures of myocardial mechanics. Echo-
cardiography is the only noninvasive method that
can accurately predict LV filling pressures, and it is
the most practical technique for evaluating myocar-
dial mechanics.
The VALIANT (Valsartan in Acute Myocardial
Infarction) echocardiographic study prospectively
enrolled 603 patients with LV dysfunction, heart
From the *Leiden University Medical Center, the Netherlands; and the
†Division of Cardiology, University Health Network, Toronto General
Hospital, Toronto, Ontario, Canada.Manuscript received April 28, 2008; accepted May 1, 2008.failure (HF), or both following a MI (mean: 5
days). The investigators presented their data in 3
separate studies looking at the prognostic signifi-
cance of Doppler-derived mitral deceleration time
(DT), strain and strain rate imaging, and the
presence of mechanical asynchrony. Jusczynska et al.
(1) assessed whether changes in the LV filling pattern
over the first month after MI were related to outcome.
Doppler profiles were analyzed in 425 patients at
baseline and in 405 stable patients 1 month after MI.
Patients with a DT140 ms (n 115 at baseline and
n  72 at 1 month) were categorized as having
restrictive physiology. In an adjusted multivariable
Cox regression model, DT  140 ms was associated
with an increased risk of death/HF at baseline (hazard
ratio [HR]: 1.7; 95% confidence interval [CI]: 1.6 to
2.6, p  0.01) and at 1-month follow-up (HR: 2.8;
95% CI: 1.8 to 4.4, p  0.001). Patients who had a
persistently restrictive pattern carried the highest risk
(HR: 2.9; 95% CI: 1.6 to 5.3, p  0.001), and those
who changed from a restrictive (at baseline) to normal
filling pattern (at 1 month) had the same prognosis
(HR: 1.4; 95% CI: 0.7 to 2.8, p 0.3) as patients with
a persistently normal LV filling pattern (Fig. 1). Thus,
as has been shown in other conditions, a restrictive
filling pattern is associated with worsened outcomes.
Conversion from a restrictive to a normal pattern
within the first month after MI is associated with a
marked improvement in prognosis.
The VALIANT investigators also used Velocity
Vector Imaging (VVI, Siemens Medical Systems,
Mountain View, California), a form of B-mode
speckle tracking, to evaluate whether strain and
strain rate (n  380) (2) and asynchrony (n  377)
(3) were predictors of death/HF. A total of 61
(16%) patients died during a median follow-up of
25 months. Both LV strain (HR: 1.21; 95% CI:
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526.05 to 1.4, p  0.006) and strain rate (HR [per
s]: 1.01; 95% CI: 1.007 to 1.01, p  0.001)
ndependently predicted death. The addition of
train rate provided incremental prognostic infor-
ation beyond the left ventricular ejection fraction
LVEF), improving the model for predictors of
ortality (C statistic increased from 0.74 to 0.86 [p
0.001]). The presence of mechanical asynchrony
as assessed by measuring time to regional peak
elocity and strain rate from 12 LV segments from
pical views. The presence of asynchrony, as deter-
ined by an increased standard deviation of these 2
easurements, was an independent predictor of
eath/HF.
The MeRGE-AMI (Meta-analysis Research
roup in Echocardiography in acute MI) study
nvestigators (4) also showed that a restrictive filling
attern (DT 140 ms) is a predictor of mortality
ollowing acute MI. The study involved a collabo-
ation of 12 prospective echocardiographic studies
ssessing the relationship between LV filling pat-
ern and outcome in patients with acute MI. An
nalysis evaluating echocardiographic measures was
erformed in a subgroup of 1,746 patients with
illip class recorded during hospitalization. Only
4% of patients presenting with severe HF (Killip
lass III or IV) had impaired LV systolic function
ith an EF  40%, but 76% had a restrictive filling
attern. The presence of this restrictive pattern was
predictor of mortality, regardless of the presence
f HF, with an odds ratio (OR) of 2.36 (95% CI:
Kaplan-Meier Estimation of Death or Heart Failure
deceleration time from baseline to 1-month follow-up from the
ial. Reprinted, with permission, from Jusczynska et al. (1). HF 
e; HR  hazard ratio..44 to 3.87) for Killip class I, OR: 2.30 (95% CI: m.48 to 3.60) for Killip class II, and OR: 3.63 (95%
I: 1.57 to 8.36) for Killip class III/IV patients.
ecanalization of Acutely Occluded
oronary Arteries: Faster is Better
arlier recanalization of acutely occluded coronary
rteries saves myocardium and improves prognosis.
ie et al. (5) showed that the use of high mechan-
cal index ultrasound and targeted microbubbles
ided recanalization in a pig model of acutely
hrombosed left anterior descending arteries. Con-
rast pulse sequencing–guided high mechanical in-
ex ultrasound was applied during infusions of
ither half-dose prourokinase alone (controls), fi-
rinolytic and nontargeted microbubbles (MRX-
35), and fibrinolytic and glycoprotein IIb/IIIa
argeted microbubbles (MRX-802). The pigs ran-
omized to targeted microbubbles had a 50% re-
analization rate at 30 min (p  0.05 compared
ith controls) and 57% recanalization rate at 90
in. The pigs randomized to nontargeted micro-
ubbles achieved a similar recanalization rate but at
later time interval (36% at 30 min and 50% at 90
in compared with 7% and 21%, respectively, for
he control group). Thus, the use of targeted mi-
robubbles administered with fibrinolytic therapy
ay play an important role in strategies for earlier
nd more effective recanalization (Figs. 2 and 3).
afety and Efﬁcacy of Available Echocardiographic
ontrast Agents in a Clinical Setting
he use of echocardiographic contrast agents to
nhance LV endocardial borders has significantly
ncreased the accuracy of echocardiography in se-
ected populations. Many investigational studies
ave also shown that these agents could evaluate
yocardial perfusion. Recently, the Food and Drug
dministration (FDA) questioned the safety of
chocardiographic contrast agents in a number of
cute care clinical settings based on a small number
f reports of death within 30 min of contrast
dministration. This led to a black box warning and
autions about appropriate use. Since that time, this
ction has generated controversy as to whether the
arning was appropriate based on the available
vidence. A study by Dolan et al. (6) was presented
n which 7,961 patients with suspected coronary
rtery disease (CAD) underwent stress echocardi-
graphy and received a perflutren-based contrast
gent, either Optison or Definity, the only 2 agents
urrently approved by the FDA. Evaluation ofFigure 1.
Changes in
VALIANT tryocardial wall motion and perfusion were studied.
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527here were no deaths within 30 min of contrast
dministration, and 1 death and 3 nonfatal MIs had
ccurred at 24 h. By sequential Cox proportional
azards regression analysis, both wall motion and
yocardial perfusion analysis independently in-
reased the predictive value of stress echocardiog-
aphy over clinical risk factors and LVEF. Patients
ith abnormal perfusion despite normal wall mo-
ion during dobutamine stress echocardiography
ad a worse event-free survival than patients with
ormal wall motion and normal perfusion (p 
.001). In their oral presentation, the investigators
xpanded on their data to include data on 23,659
onsecutive patients from multiple centers under-
oing contrast studies (at rest), and there were no
eaths within 30 min in this large cohort. Compar-
sons were also made between the group of patients
eceiving contrast (for suboptimal images) and a
atched group (with optimal images) not requiring
ontrast, and the cardiac event rates were not
ifferent. Therefore, it appears that the risk of death
r MI after contrast use is very low and comparable
ith patients who did not receive contrast. The
nvestigators concluded that the benefits of contrast
se in patients with suboptimal images are signifi-
ant, outweigh the possible small risks, and that the
DA should review and amend its policy.
uantitation of LV Volumes:
omparison of Magnetic Resonance Imaging
nd 3-Dimensional Echocardiography
ccurate quantitation of LV volumes is important
Figure 2. Microbubble Treatment of Coronary Occlusion in a Pig
Left panel shows left anterior descending (LAD) occlusion in a porc
right panel 30 min after targeted microbubble treatment. Reprintedn the evaluation of disease severity and prognosis of aatients with heart disease. Although magnetic
esonance imaging (MRI) remains the gold stan-
ard for quantification of LV volumes, echocardi-
graphy is more frequently used to evaluate most
orms of heart disease. Real-time 3-dimensional
chocardiographic (RT3DE) evaluation of LV vol-
mes is more robust than 2-dimensional studies.
or-Avi et al. (7) conducted a multicenter study to
valuate the accuracy and reproducibility of
T3DE compared with MRI in 92 patients. They
valuated the interinstitutional differences and po-
ential sources of disagreement. The RT3DE-
erived volumes correlated highly with MRI (end-
iastolic volume: r 0.91, end-systolic volume: r
.93) but their values were 29% and 26% lower.
his difference was similar across participating
nstitutions, with the magnitude of the bias being
irectly related to the level of training. The consis-
ent underestimation of RT3DE-derived LV vol-
mes was attributed to tracing of trabeculae. To
inimize this difference, tracing the endocardium
o include trabeculae in the LV cavity was recom-
ended.
o Scars and Viability Predict Prognosis?
he MRI studies using gadolinium to detect de-
ayed enhancement (DE) can accurately determine
he amount of myocardial fibrosis and scarring.
everal studies used this important tool to predict
iability and outcome. Kwon et al. (8) evaluated 349
atients with severe ischemic cardiomyopathy
mean EF: 24%). The percentage of myocardium
model of acute coronary occlusion. Recanalization is seen in the
ith permission, from Xie et al. (5).ineffected by scarring and a transmurality score were
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528sed to predict the outcomes of death (n  51) or
ardiac transplantation (n  5). Events could be
redicted by the total scar score  2.3 (relative risk
RR]: 1.96; 95% CI: 1.13 to 3.41, p  0.05) and
emale gender (RR: 1.83; 95% CI: 1.06 to 3.16, p
.05). Lenge et al. (9) evaluated 183 patients in an
nternational multicenter myocardial viability trial
o predict recovery of LV function after revascular-
zation by coronary artery bypass graft surgery or
ercutaneous coronary intervention (PCI). At base-
ine, 5,580 of 12,274 (46%) segments had abnormal
ontractility, and 2,975 (24%) had DE. Improve-
ent in contractility of impaired segments follow-
ng revascularization correlated inversely with the
ransmural extent of scarring (r2  0.9). Following
evascularization, 72% of dysfunctional segments
ithout a scar at baseline showed improved con-
ractility, and 52% of such segments had complete
ecovery of function (p  0.001). Maron et al. (10)
valuated the significance of DE in 202 patients
ith hypertrophic cardiomyopathy. Delayed en-
ancement was present in all 10 patients with EF
elow 50%, 9 of 10 (90%) with EF 51% to 59%, and
4 of 182 (45%) with EF  60% (p  0.001).
lthough the cardiovascular event rate was higher
n patients with DE, it did not reach statistical
ignificance. Therefore, DE is an important predic-
Figure 3. Progressive Increase in Myocardial Contrast Enhancem
An example of the progressive increase in myocardial contrast enha
the treatment of a left coronary occlusion with intravenous-targeted
Reprinted, with permission, from Xie et al. (5).or of outcome and viability in CAD. In conditions auch as hypertrophic cardiomyopathy, further stud-
es in larger groups of patients are required to better
nderstand its importance and role in clinical deci-
ion making.
Roes et al. (11) performed a study comparing
yocardial viability assessment with contrast-
nhanced MRI to viability assessment using 99mTc-
etrofosmin single-photon emission computed to-
ography (SPECT) and 18F–fluorodeoxyglucose
FDG) SPECT in 25 patients with severe ischemic
V dysfunction. Dysfunctional segments were cat-
gorized in viability patterns assessed with SPECT:
ormal pattern (normal perfusion and metabolism),
ismatch (decreased perfusion, increased metabo-
ism), mild match and severe match (mild and
evere decrease in perfusion and metabolism).
greement between MRI and nuclear imaging for
ssessment of viability is strong in segments with
ransmural infarction on contrast-enhanced MRI.
owever, nonenhanced tissue on contrast-
nhanced MRI can be normal or jeopardized
perfusion-metabolism mismatch) myocardium
Fig. 4).
Another interesting application of DE was re-
orted by Badger et al. (12) and described a new
ethod to detect abnormal electrical tissue by com-
aring DE-MRI images with electroanatomical volt-
ment within the central portion of the risk area (arrows) during
icrobubbles and intermittent high mechanical index impulses.ent
nce
mge maps. Atrial fibrillation is associated with electro-
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529hysiological remodeling of the left atrium, which
esults in regions of low-voltage tissue (Fig. 5). Their
reliminary studies showed that DE-MRI seems to be
easible for detecting low-voltage areas in the left
trium and might be used for pre-procedural planning
o distinguish healthy tissue from remodeled tissue,
hus guiding the ablation procedure.
yocardial Perfusion Imaging and Prognosis
lthough the prognostic value of stress myocardial
erfusion SPECT (MPS) is well defined, the iden-
ification of long-term post-MPS therapeutic ben-
fit with revascularization versus medical therapy is
nknown. Hachamovitch et al. (13) identified
0,609 patients who underwent MPS and followed
hese patients for an average of 3 years. Early
evascularization ( 60 days post-MPS) was per-
ormed in 890 patients (8.4%). All-cause death
ccurred in 2,627 (25%) patients. In this observa-
ional study, a threshold of 10% of the myocardium
as found to define patients with a survival benefit
rom revascularization over medical therapy, with
ncreasing amounts of ischemia associated with
ncreasing survival benefit (Fig. 6).
A proportion of patients undergoing exercise
PS show perfusion defects but no symptoms occur
uring exercise. Abidov et al. (14) evaluated the
omparative prognostic value of patients with silent
schemia compared with those patients with exercise-
nduced ischemia during MPS. Their cohort consisted
f 8,750 patients who were followed for 10 years.
atients with silent ischemia had less severe perfusion
efects as well as a lower peak heart rate. A higher rate
f silent ischemia was observed in patients with
iabetes compared with nondiabetics (28% vs. 17%,
 0.001). Silent exercise-induced ischemia was an
ndependent marker of long-term (10 years) all-cause
ortality, and it had a prognostic impact similar to
hat of symptomatic inducible ischemia.
yocardial Perfusion Imaging:
ew Agents and Techniques
number of studies were presented that evaluated the
otential beneﬁts of new myocardial perfusion imag-
ng (MPI) agents as well as strategies for improving
perational efﬁciency. Udelson et al. (15) reported
he results from the VISION (Vasodilator-Induced
tress in Concordance with Adenosine) 302 and
05 trials. The goal of this trial was to evaluate the
afety and efficacy of the highly selective adenosine
2A receptor agonist, binodenoson, for pharmaco-
ogic stress in patients at risk or with known CAD. fin the VISION 302 trial, 415 patients referred for
linical pharmacological stress MPI completed 2
ouble-blind, double-dummy MPI procedures us-
ng either binodenoson or adenosine stress in ran-
om order. No significant differences were observed
n summed defects scores with a mean difference of
0.09 (95% CI: –0.44 to 0.27). Importantly, sub-
tantial differences in summed difference score were
bserved in only 3% of patients. With regard to side
ffects, second- or third-degree atrioventricular
lock occurred in none of the binodenoson studies
ersus 3% of adenosine (p  0.004). In addition,
ther side effects, including flushing and chest pain,
ere reduced and less intense, resulting in an
vident preference of patients for binodenoson
71%) over adenosine (20%, p  0.004). Accord-
ngly, binodenoson provides similar measurement
f the extent and severity of ischemia on MPI,
hile being associated with fewer and less intense
ide effects. Maddahi et al. (16) assessed the results
f a novel 3-dimensional iterative image reconstruc-
ion technique for SPECT MPI. The diagnostic
uality of the images, quantitative perfusion defect
ize, and measurements of LV function were as-
essed in 448 patients prospectively enrolled from
0 institutions. Mean acquisition times for stress
nd rest studies were 3.5 and 4.1 min for the
SPEED technique versus 6.4 and 7.8 min for the
tandard approach. Image quality of nSPEED
tudies was identical or even better in 79% and 19%,
espectively, of cases. Importantly, 99% of studies
ere considered diagnostically equivalent and no
ignificant differences were observed in the quanti-
%
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Figure 4. Relation of Contrast-Enhanced MRI and SPECT
Relation between contrast-enhanced magnetic resonance imaging (
viability pattern assessed with single-photon emission computed to
phy (SPECT). Reprinted, with permission, from Roes et al. (11).l perfusion
MRI) and
mogra-cation of defect size or LV function variables.
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530herefore, use of nSPEED allows reduction of
mage acquisition time to one-half without loss of
mage quality or diagnostic accuracy. By using
ine-source attenuation correction, accurate stress-
nly MPI has become possible. New scan algo-
ithms and depth-dependent collimator resolution
urrently allow for shorter acquisition time by 50%
ith equivalent image quality and accuracy. Bate-
an et al. (17) evaluated the image quality and
ccuracy of using half-time stress-only acquisitions
ith line-source attenuation correction. This study
onsisted of 110 patients who underwent rest/stress
PECT with line-source attenuation correction.
alf-time scans were obtained by retrospectively
stripping” of the full-time scans. Compared with
ull-time scans, image quality, interpretive cer-
ainty, and diagnostic accuracy were equivalent in
he half-time scans. When comparing full-time to
Figure 5. MRI Correlation with Electroanatomic Maps in 3 Patie
(A) Delayed enhancement (DE) magnetic resonance imaging (MRI) r
rior wall. (B) The MRI images as color 3-dimensional models show l
tissue (blue). (C) Electroanatomic maps acquired during invasive ele
sue (colored). Nonviable tissue is shown in red. Reprinted, with peralf-time scans, quality was excellent/good in 87% tersus 89%, interpretive certainty was 95% versus
5%, sensitivity was 86% versus 82%, specificity was
3% versus 82%, normalcy was 78% versus 100%
all p  NS). Therefore, stress-only half-time
ttenuation corrected imaging can improve the
perational efficiency without sacrificing accuracy.
ccuracy and Limitations of Computed
omography Angiography (CTA):
s the Glass Half Empty or Half Full?
iagnosis. Multislice computed tomography an-
iography is an exciting method of noninvasively
roviding detailed coronary anatomy. However,
imitations include the presence of coronary calci-
cation and the presence of coronary stents. Fur-
hermore, current challenges for this modality in-
lude the identification of the clinical scenarios and
with Moderate Electrical Remodeling
als moderate enhancement in portions of the posterior left ante-
portions of abnormal tissue (green) in comparison to healthy
physiologic study show large patches of electrically abnormal tis-
sion, from Badger et al. (12). PA  pulmonary artery.nts
eve
arge
ctrohe patient subgroups that would likely benefit most
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531rom this test. Kondo et al. (18) evaluated the
mpact of CTA on clinical decision making in 2,058
onsecutive patients. Revascularization (by means
f PCI or coronary artery bypass grafting) was
onsidered as the primary end point. Their data
howed that CTA facilitated clinical management
n up to 85% of patients with CAD. However,
quivocal findings necessitated further evaluation by
eans of conventional coronary angiography in 260
13%), and conventional coronary angiography with
d hoc PCI was performed in 56 of 1,282 (4.4%) of
atients originally classified as having no significant
tenosis on CTA. In these patients, the most
ommon cause of nondiagnostic findings on CTA
as reduced image quality due to calcification, the
resence of stents (Fig. 7), or motion artifacts.
ccordingly, the clinical value of CTA remains
ower in cases of dense calcifications and stents.
revious single-center studies have demonstrated a
ood diagnostic accuracy for 64-slice CTA. Min et
l. (19) presented results of their prospective mul-
icenter trial comparing 64-slice CTA to quantita-
ive coronary angiography. During the enrolment
eriod, 232 patients were enrolled at 16 sites, and
atients underwent both CTA and conventional
uantitative coronary angiography. Quantitative
oronary angiography detected a 50% diameter
tenosis in 49 (21.3%) patients and a 70% diam-
ter stenosis in 28 (12.1%) patients (Fig. 8). The
iagnostic accuracy of CTA for the detection of
50% diameter stenosis was good, with a sensitivity
f 95%, specificity of 83%, positive predictive value
PPV) of 64%, and a negative predictive value
NPV) of 99%. The diagnostic accuracy of CTA
ncreased slightly when using the 70% threshold.
his prospective multicenter trial illustrates that
4-slice CTA indeed has a good diagnostic accu-
acy, and that the high NPV (98% to 99%) makes it
very effective technique to exclude obstructive
oronary stenosis. The positive predictive value
emains suboptimal for making decisions about
oronary intervention. This observation was sup-
orted by a multicenter study from Meijboom et al.
20) that enrolled 360 symptomatic patients in a
tudy comparing 64-slice CTA to conventional
oronary angiography. In a segment-based analysis,
he sensitivity for detection of a coronary stenosis of
50% was 88%; specificity was 90%, with a PPV of
nly 47% but a NPV of 99%. The diagnostic
ccuracy for this technique was even lower in
atients assessed for in-stent restenosis. Haralds-
ottir et al. (21) studied 93 patients with a total of
40 stents. The sensitivity, specificity, PPV, and (PV for the detection of restenosis by CTA was
6%, 90%, 35%, and 85%, respectively. Thus the
resence of significant coronary calcium as well as
revious stent insertions remain significant chal-
enges with this technique.
ost-effectiveness. An important issue currently is
he lack of cost-effectiveness data for the use of
TA. To address this issue, Min and colleagues
22) compared the cost-effectiveness of CTA with
atched patients undergoing MPI using the re-
ently assigned transaction codes. Cost- and
linical-effectiveness were determined in the 9
onths following the initial testing based on down-
tream CAD costs and clinical CAD events. In
otal, 2,313 patients who underwent CTA were
atched (1:4) to a cohort of 9,252 patients who
nderwent MPI. No differences were observed in
he rate of clinical events between the 2 groups. The
ate of PCI was slightly higher after CTA as
ompared with MPI. However, use of CTA was
emonstrated to result in a 9% cost reduction. This
eduction was attributable to CAD-naïve patients.
n contrast, use of MPI was shown to be more
ost-effective than CTA in patients with known
AD.
adiation exposure. An important issue in deciding
bout the risks or benefits of CTA is the radiation
ose. Hausleiter et al. (23) investigated the magni-
ude of the radiation dose and the efficacy of
ose-saving algorithms. During 1 month, the in-
ormation from 1,965 CTA’s was collected from 44
tudy sites worldwide. The mean radiation dose was
7.1 mSv but differed significantly between study
ites (8.5 to 43.8 mSv) and between scanner systems
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532sing tube modulation and lowered X-ray energy
100 kV instead of 120 kV) were shown to result in
ignificant lowering of estimated radiation dose.
owever, these techniques were infrequently used.
ccordingly, dose-saving algorithms should be im-
lemented more frequently to enable the more
idespread use of this promising technique.
Figure 7. CT Angiogram of Stented Patient
A computed tomography (CT) angiogram taken from a patient with
tion of the coronary lumen can be seen. Reprinted, with permission
 left circumﬂex artery; MDCT  multidetector computed tomogra
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Figure 8. ROC Curve at 70% Stenosis Threshold Detection by C
The receiver-operator characteristic (ROC) curve at 70% stenosis thr
(CCTA). Reprinted, with permission, from Min et al. (19). AUC  area unusion of CTA With MPI:
re 2 Heads Better Than 1?
yocardial perfusion imaging using SPECT pro-
ides good sensitivity and specificity in the detec-
ion of CAD as well as providing important prog-
ostic information. Computed tomography
onary stenting. The effects of stent placement on the visualiza-
m Kondo et al. (18). LAD  left anterior descending artery; LCX
; RCA  right coronary artery.
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533ngiography is an exciting method of providing
oninvasive coronary anatomy and atherosclerotic
urden. Does a combination of the 2 tests provide
mportant incremental information, or does it result
n just more cost and radiation exposure? Slomka et
l. (24) studied 38 patients who previously under-
ent MPI, 64-slice CTA, and invasive coronary
ngiography—quantitative MPI and CT images
ere automatically fused using a dedicated algo-
ithm. Combination with the anatomical CTA data
esulted in adjustment of MPI territories in 10
tudies, whereas LV contours were improved in 5.
lternatively, the functional MPI data facilitated
TA diagnosis in cases of heavy calcifications
present in 30 patients) and motion artifacts (8
atients); an example of which is shown in Figure 9.
ccordingly, the retrospective fusion may have the
otential to improve diagnosis; anatomical CTA
ata may guide assessment of LV contours and
ascular territories on MPI, whereas the functional
ata on MPI may improve evaluation of the CTA
ata. The investigators concluded that the combi-
ation of studies has the potential to optimize the
iagnosis of CAD in specific vessels by adding
natomic data to MPI and resolving CT calcifica-
ion and motion artifacts with the correlating per-
usion data. More data are required to determine
hether this strategy is safe and cost-effective.
uzsics et al. (25) took a different and interesting
pproach: they performed contrast-enhanced dual-
nergy (dual source) CT coronary angiography
DSCT) in 35 patients with 1 X-ray tube set at 140
V and the second set at either 100 kV or 80 kV.
ubsequently, the myocardial iodine distribution
rom the low kilovoltage spectra was mapped on
irtual non–contrast-enhanced multiplanar refor-
ats in the short- and long-axis orientation,
hereby visualizing blood-pool deficits (Fig. 10).
esults were compared with invasive coronary an-
iography and SPECT. In total, 595 segments were
valuated and 126 segments in 24 patients showed
yocardial blood pool deficit. In all of these pa-
ients, significant stenosis in the corresponding
oronary arteries was detected by DSCT. On a
egmental basis, DSCT detected myocardial isch-
mia with 84% sensitivity, 94% specificity, and 92%
ccuracy as compared with SPECT. In patients
ithout significant CAD (n  7), no sign of
ypoattenuation was observed representing normal
yocardial blood distribution, which was con-
rmed by SPECT. Finally, accuracy for the evalu-
tion of significant stenosis as compared with inva-
ive coronary angiography was also excellent. dccordingly, these initial observations suggest that
SCT may allow comprehensive analysis of coro-
ary artery morphology and the myocardial blood
ool in good agreement with MPI and invasive
oronary angiography.
Komatsu et al. (26) performed an ex vivo study to
etermine the accuracy of plaque characterization
ith DSCT in 22 atherosclerotic vessels obtained
rom autopsy. The DSCT datasets were obtained
sing different tube voltages ranging between 80
nd 140 kV. The attenuation of lipid-rich plaque,
brous plaque, calcified plaque, and contrast-
nhanced lumen was assessed for all X-ray energies
nd compared with histology at 25 sites. For each
laque type, the ratio between the attenuation of
he plaque tissue and the contrast-filled lumen
hanged significantly between differing X-ray ener-
ies. The averaged ratio of CT attenuation of
ipid-rich plaque, fibrous plaque, and calcified
laque to the contrast-enhanced lumen for 80 kV
nd 140 kV were –16%, 11%, and 14%, respectively
p  0.05). By varying the X-ray energy, DSCT
ay therefore facilitate detection of atherosclerotic
laque and characterization of plaque components.
Yet another combination approach was taken by
ogers et al. (27) who evaluated the correlation
etween inflammation as detected by 18F-FDG
ositron emission tomography in coronary plaques
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Figure 9. SPECT/CTA Fusion
Example of the single-photon emission computed tomography/com
tomography (SPECT/CTA) fusion in a case in which adjustment of v
plane position in SPECT contours guided by the CTA allowed correc
ﬁcation of the RCA lesion (shown in black) by SPECT. The RCA was
mined to have 100% occlusion by coronary angiography. The origin
contours resulted in a false negative SPECT ﬁnding. The LAD and L
lesions could not be evaluated by CTA due to heavy calciﬁcation, b
corresponding territories were normal in SPECT, which was conﬁrm
coronary angiography. Reprinted, with permission, from Slomka et
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534arkers of inflammation in 25 patients. Of these
atients, 10 underwent PCI because of acute coro-
ary syndromes, whereas 5 underwent PCI for
table angina. The remaining 10 patients had stable
ngina and underwent diagnostic coronary angiog-
aphy but did not require PCI. The plaque inflam-
atory signal, measured as FDG activity (T/B) in
he plaques requiring PCI for acute coronary syn-
romes or stable angina were significantly related
ith levels of C-reactive protein (r  0.58), immu-
oglobin M (r  0.77), interleukin-12 p70 (r 
.62), tumor necrosis factor-alpha (r  0.56), all
  0.05. Finally, levels of log C-reactive protein
nd interleukin-12 p70 were significantly different
etween patients stented for acute coronary syn-
romes and patients stented for stable angina.
ccordingly, the investigators conclude that
ositron emission tomography imaging in combi-
ation with CTA may be a promising tool to
dentify plaque inflammation and may be valuable
Figure 10. Myocardial Iodine Distribution in CT and SPECT Imag
First panel shows signiﬁcant right coronary artery lesion (arrow). Seco
lesion (arrow). Third panel shows single-photon emission computed t
shows dual-energy CT image showing corresponding defect (double aColl Cardiol 2008;51 Suppl A:A142. Patient Meta-analyso therapy. This is another promising approach that
equires greater validation.
onclusions
he American College of Cardiology Scientific
ession again provided an important forum for the
resentation of new technologies and gave us in-
ights into their integration into clinical practice as
ell as their limitations. Although beautiful images
r elegant techniques are initially impressive, the
rue test of value will be in their ability to enhance
ur understanding of cardiovascular disease and
mprove patient outcomes. Knowing how to choose
he right test for the right patient awaits the test of
ime.
eprint requests and correspondence: Dr. Harry Ra-
owski, Toronto General Hospital, 200 Elizabeth Street,
N-504, Toronto, Ontario, Canada M5G2C4. E-mail:
anel shows corresponding computed tomography (CT) angiogram
graphy (SPECT) perfusion defect (double arrow), and fourth panel
). Reprinted, with permission, from Ruzsics et al. (25).for risk assessment as well as monitoring response harry.rakowski@uhn.on.ca.E F E R E N C E S
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